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Abstract
Inhibitors of EZH2 methyltransferase activity have been demonstrated to selectively suppress
the growth of diffused large B cell lymphoma (DLBCL) cells with gain-of-function mutations in
EZH2, while exhibiting very limited effects on the growth of DLBCL cells with wild-type EZH2.
Given that EZH2 is often overexpressed but not mutated in solid tumors, it is important to
investigate the determinants of sensitivity of solid tumor cells to EZH2 inhibitors. In the current
study, we show that three-dimensional (3D) culture of epithelial ovarian cancer (EOC) cells that
overexpress EZH2 sensitizes these cells to EZH2 methyltransferase inhibition. Treatment of EOC
cells  with  GSK343,  a  specific  inhibitor  of  EZH2  methyltransferase,  decreases  the  level  of
H3K27Me3, the product of EZH2's enzymatic activity. However, GSK343 exhibited limited effects
on the growth of EOC cells in conventional two-dimensional (2D) culture. In contrast, GSK343
significantly suppressed the growth of EOC cells cultured in 3D matrigel extracellular matrix
(ECM),  which  more  closely  mimics  the  tumor  microenvironment  in  vivo.  Notably,  GSK343
induces apoptosis of  EOC cells  in 3D but not 2D culture.  In addition,  GSK343 significantly
inhibited the invasion of EOC cells. In summary, we show that the 3D ECM sensitizes EOC cells
to EZH2 methyltransferase inhibition,  which suppresses cell  growth,  induces apoptosis  and
inhibits  invasion.  Our  findings  imply  that  in  EZH2 wild-type  solid  tumors,  the  ECM tumor
microenvironment plays an important role in determining sensitivity to EZH2 inhibition and
suggest  that  targeting  the  ECM represents  a  novel  strategy  for  enhancing  EZH2 inhibitor
efficacy. © 2013 Landes Bioscience.
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